Reference: Francesca Urbani; Virginia Ferraresi; Imerio Capone; Iole Macchia; Belinda Palermo; Carmen Nuzzo; Angela Torsello; Patrizio Pezzotti; Diana Giannarelli; Anna Fausta Pozzi; Mariano Santaquilani; Paolo Roazzi; Silvia Bastucci; Caterina Catricalà; Antonia La Malfa; Giuseppe Vercillo; Novella Gualtieri; Carla Buccione; Luciano Castiello; Francesco Cognetti; Paola Nisticò; Filippo Belardelli; Federica Moschella; Enrico Proietti. "Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study." Frontiers in oncology (2020).

Epitope: Melan-A 26−35 (A27L)
Chemical type: Peptide, no natural source
Sequence: ELAGIGILTV
Assay category: TCell
Result: Positive-Low
Host:  23-80 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: Melan-A 26−35 (A27L)
Chemical type: Peptide, no natural source
Sequence: ELAGIGILTV
Assay category: TCell
Result: Positive
Host:  23-80 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: Melan-A 26−35 (A27L)
Chemical type: Peptide, no natural source
Sequence: ELAGIGILTV
Assay category: TCell
Result: Positive
Host:  23-80 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: Melan-A 26−35 (A27L)
Chemical type: Peptide, no natural source
Sequence: ELAGIGILTV
Assay category: TCell
Result: Positive
Host:  23-80 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: Melan-A 26−35 (A27L)
Chemical type: Peptide, no natural source
Sequence: ELAGIGILTV
Assay category: TCell
Result: Positive
Host:  23-80 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: Melan-A 26−35 (A27L)
Chemical type: Peptide, no natural source
Sequence: ELAGIGILTV
Assay category: TCell
Result: Positive
Host:  23-80 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: Melan-A 26−35 (A27L)
Chemical type: Peptide, no natural source
Sequence: ELAGIGILTV
Assay category: TCell
Result: Positive
Host:  23-80 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: Melan-A 26−35 (A27L)
Chemical type: Peptide, no natural source
Sequence: ELAGIGILTV
Assay category: TCell
Result: Positive
Host:  23-80 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: Melan-A 26−35 (A27L)
Chemical type: Peptide, no natural source
Sequence: ELAGIGILTV
Assay category: TCell
Result: Positive
Host:  23-80 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: Melan-A 26−35 (A27L)
Chemical type: Peptide, no natural source
Sequence: ELAGIGILTV
Assay category: TCell
Result: Positive
Host:  23-80 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: NY-ESO-1 157−165
Chemical type: Peptide from protein
Sequence: SLLMWITQC
Position: 157-165
Source molecule (GenBank): CAA05908.1
Assay category: TCell
Result: Positive
Host:  23-80 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: NY-ESO-1 157−165
Chemical type: Peptide from protein
Sequence: SLLMWITQC
Position: 157-165
Source molecule (GenBank): CAA05908.1
Assay category: TCell
Result: Positive-Low
Host:  23-80 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo